All questionsPharmacology: Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer4 questions · 2 sourcesMechanismHow does TRODELVY work (mechanism of action)?“Sacituzumab govitecan-hziy is a Trop-2-directed antibody-drug conjugate. Sacituzumab is a humanized antibody that recognizes Trop-2. The small molecule, SN-38, is a topoisomerase I inhibitor, which is covalently attached to the antibody by a linker. Pharmacology data suggest that sacituzumab govitecan-hziy binds to Trop-2-expressing cancer cells and is internalized with the subsequent release of SN-38 via hydrolysis of the linker. SN-38 interacts with topoisomerase I and prevents re-ligation of topoisomerase I-induced single strand breaks. The resulting DNA damage leads to apoptosis and cell death.” (opens the source at this quote in a new tab)CopyFlag“Once internalized, the CL2A linker may allow the release of SN-38 directly into Trop-2–expressing cells, including tumor cells, and then into the tumor microenvironment and nearby tumor cells—known as the bystander effect.” (opens the source at this quote in a new tab)CopyFlag“The mechanism of action, including the bystander effect, is suggested based on preclinical data, which may not correlate with clinical outcomes.” (opens the source at this quote in a new tab)CopyFlagPharmacokineticsHow is TRODELVY metabolized?“No metabolism studies with sacituzumab govitecan-hziy were conducted. SN-38 (the small molecule moiety of sacituzumab govitecan-hziy) is metabolized via UGT1A1. The glucuronide metabolite of SN-38 (SN-38G) was detectable in the serum of patients.” (opens the source at this quote in a new tab)CopyFlagWhat is the half-life of TRODELVY?“The median elimination half-life (t1/2) of sacituzumab govitecan-hziy is 6.5 days and free SN-38 is 22 hours. The terminal half-life (t1/2) of sacituzumab govitecan-hziy is 6.7 days (23%) and the apparent half-life (t1/2) of free SN-38 is 24 hours (50%). The clearance of sacituzumab govitecan-hziy is 0.13 L/h (20%).” (opens the source at this quote in a new tab)CopyFlagComponentsWhat are the ingredients in TRODELVY?“Each single-dose vial of TRODELVY delivers 180 mg sacituzumab govitecan-hziy, 71.7 mg 2-(N-morpholino) ethane sulfonic acid (MES), 1.8 mg polysorbate 80 and 153.99 mg trehalose.” (opens the source at this quote in a new tab)CopyFlag